Analysis on distribution and drug resistance of carbapenem-resistant Acinetobacter baumannii infections
10.3969/j.issn.1671-8348.2016.21.025
- VernacularTitle:耐碳青霉烯类鲍曼不动杆菌的感染分布及耐药性分析
- Author:
Lei HE
;
Chunhua LI
;
Daobin JIANG
- Publication Type:Journal Article
- Keywords:
carbapenem-resistant Acinetobacter baumannii;
community infection;
nosocomial infection;
drug resistance
- From:
Chongqing Medicine
2016;45(21):2966-2968,2972
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the distribution of carbapenem‐resistant Acinetobacter baumannii(CRAB) infections and its resistance to commonly used antibacterial drugs to provide a basis for infection control and rational use of antibacterial drugs in this area .Methods The clinical data and drug susceptibility test results in the patients with CRAB infection in our hospital from January 1 ,2013 to December 31 ,2014 were retrospectively analyzed .Results Eighteen strains of CRAB in community‐acquired in‐fection and 140 strains of CRAB in nosocomial infection were isolated ,the resistance rates to piperacillin/tazobactam ,gentamicin and tobramycin were higher than 80% ,which to ampicillin/sulbactam and levofloxacin were 64 .5% and 48 .2% respectively ,which to compound SMZ and amikacin were lower than 25% .The distribution of drug sensitivity results had no statistical difference between community CRAB infection and nosocomial CRAB infection (P>0 .05) .Conclusion The CRAB infection is mainly nosocomial in‐fection ,the empirical therapy could select compound SMZ and amikacin .
